1-Adamantanecarboxylic acid → HCID 178467909, compound
Reaction equation
[CH3:1][C:2]1[N:3]=[C:4]([NH2:8])[S:5][C:6]=1[CH3:7].Br[CH2:10][CH2:11][O:12][CH2:13][CH3:14].[C:15]12([C:25](O)=[O:26])[CH2:24][CH:19]3[CH2:20][CH:21]([CH2:23][CH:17]([CH2:18]3)[CH2:16]1)[CH2:22]2>>[CH2:11]([O:12][CH2:13][CH2:14][N:3]1[C:2]([CH3:1])=[C:6]([CH3:7])[S:5]/[C:4]/1=[N:8]\[C:25]([C:15]12[CH2:24][CH:19]3[CH2:18][CH:17]([CH2:23][CH:21]([CH2:20]3)[CH2:22]1)[CH2:16]2)=[O:26])[CH3:10]Participants
4
Procedure
4,5-Dimethylthiazol-2-ylamine, 1-bromo-2-ethoxyethane and 1-adamantane carboxylic acid were processed as described in Example 47 to afford the title compound. 1H NMR (CDCl3, 500 MHz) δ ppm 1.05 (t, J=7.02 Hz, 3 H) 1.61-1.76 (m, 6 H) 1.84 (d, J=2.50 Hz, 6 H) 1.95-2.03 (m, 3 H) 2.16 (s, 3 H) 2.21 (s, 3 H) 3.43 (q, J=7.07 Hz, 2 H) 3.69 (t, J=5.46 Hz, 2 H) 4.24 (t, J=5.46 Hz, 2 H); MS (ESI) m/z 363 (M=H)+.
Sources & evidence
- ORD record
- ord-fddf9b0644fd4d4689b74f63bb01f978
- Source dataset
- uspto-grants-2011_01
- Patent number
- US07875639B2
Reaction notes
Loading…